Schizophrenia has emerged as one of the most debilitating psychiatric disorders, and it impacts on an individual’s quality of life. Its prevalence is approximately 1.0%, whereas its incidence ranges from 0.16 to 0.42/1000 individuals. Evidence indicates that genetics have an integral role in the onset of schizophrenia. Some of genes involved in the development of schizophrenia include RELN gene, GRM3 gene, COMT gene, and NOS1AP gene. Similarly, neurological dysfunctions including dopamine and glutamate dysfunction have been identified as some of the main factors underlying the pathophysiology of the disorder. Overall, there is evidence that support the biological basis of schizophrenia.
Table of Contents
1. Introduction
2. Genetic Basis of Schizophrenia
3. Neurobiological Basis of Schizophrenia
4. Conclusion
Research Objectives and Themes
This paper aims to provide comprehensive insight into the biological basis of schizophrenia by examining the genetic and neurological mechanisms that contribute to the pathophysiology of this debilitating disorder.
- The role of specific genes in the development of schizophrenia
- Epidemiological data regarding genetic transmission and risks
- The impact of glutamate and dopamine dysregulation
- Interneuron dysfunction and its link to clinical symptoms
- Structural DNA changes and their connection to neurodevelopmental vulnerability
Excerpt from the Book
Genetic Basis of Schizophrenia
In retrospect, epidemiological studies reveal that genetic mechanisms could be responsible for the onset of schizophrenia among the global population. Initial studies linked the risk of schizophrenia to genetics based on the findings which revealed the existence of the disorder among biologic relatives. In these studies, it was found out that schizophrenia did not occur in adopted relatives in the same magnitude as compared to its prevalence in biologic relatives (Ketty et al., 1994). Findings indicate that first-degree relatives of schizophrenic patients have a high risk of suffering from schizophrenia. This group of people experience as high as 10% of schizophrenia risk. One the other hand, the risk of schizophrenia among children who are born of schizophrenic parents is estimated at 40%, primarily when both parents are suffering from the disorder. Further findings reveal that twins bear differing risks in which monozygotic twins are reported to a schizophrenic concordance of 40% to 50% compared to 10% reported in dizygotic twins (Frankenburg, 2015).
Over the past few decades, extensive genomic studies have been conducted to investigate the genetic basis of schizophrenia. These studies have led to the identification of the key genes which are involved in the onset of schizophrenia. An outstanding genome-wide study which provided insight into the genetic basis of schizophrenia is the recent study that was carried out by Ripke et al. (2014). In this study, investigators identified 108 genetic loci which are associated to schizophrenia. Most of these genetic loci had not been identified in the previous studies. Overall findings in this study indicated that the identified gene loci were involved in the expression of key genes in the brain, as well as the immune system tissues. Some of the genetic loci which have became candidates for genetic study on the genetic basis of schizophrenia include RELN gene, GRM3 (metabotrophic glutamate receptor 3) gene, COMT (catechol-O-methyltransferase) gene, and NOS1AP (nitric oxide synthase adaptor protein) gene.
Summary of Chapters
1. Introduction: This chapter outlines the clinical prevalence and social impact of schizophrenia while establishing the necessity of investigating its underlying biological and physiological causes.
2. Genetic Basis of Schizophrenia: This section reviews evidence from genomic studies and epidemiological data to detail how specific gene variants and hereditary patterns contribute to the onset of the disorder.
3. Neurobiological Basis of Schizophrenia: This chapter explores the pathophysiology of the disease through key scientific theories, focusing on glutamate dysfunction, dopamine hyperactivity, and interneuron impairment.
4. Conclusion: The concluding chapter synthesizes the evidence to confirm that genetic changes and neurological dysfunctions form a strong biological foundation for the presentation of schizophrenic symptoms.
Keywords
Schizophrenia, Genetics, Pathophysiology, Neurobiology, Dopamine, Glutamate, RELN gene, COMT, NOS1AP, Interneuron dysfunction, Psychiatry, Mental Health, Genome-wide study, Psychotic symptoms, Neurodevelopmental genes
Frequently Asked Questions
What is the primary focus of this research paper?
The paper focuses on identifying the biological foundations of schizophrenia, specifically examining genetic predispositions and neurobiological mechanisms.
What are the core thematic areas discussed in the text?
The core themes include epidemiological evidence of genetic risk, the identification of specific risk-associated genes, and the role of neurotransmitter imbalances and interneuron dysfunction in the brain.
What is the central research question addressed by the author?
The author seeks to determine how genetic and neurological mechanisms function as the primary underlying factors responsible for the pathophysiology of schizophrenia.
Which scientific methodology does the paper utilize?
The paper employs a review-based methodology, synthesizing findings from various genomic studies, epidemiological data, and prospective laboratory research on brain samples.
What topics are covered in the main body of the work?
The main body treats the genetic basis through a review of familial studies and genomic loci, followed by an analysis of the glutamate and dopamine hypotheses regarding neurological function.
Which keywords best characterize this publication?
Key terms include Schizophrenia, Genetics, Neurobiology, Pathophysiology, Dopamine, Glutamate, and various gene markers like COMT and RELN.
How does the paper explain the prevalence of schizophrenia in families?
The author notes that epidemiological studies show significantly higher risks among biologic relatives compared to adoptive ones, suggesting a strong hereditary component involving specific genetic loci.
What role does the COMT gene play according to the text?
The COMT gene is involved in producing the COMT enzyme, which regulates catecholamine neurotransmitters like dopamine; variations in this gene can lead to faster degradation of dopamine, potentially worsening psychotic symptoms.
What is the clinical significance of the glutamate hypothesis?
The glutamate hypothesis suggests that impaired NMDA receptor activity and low concentrations of glutamate receptors contribute to cognitive difficulties and reduced functioning in the hippocampal and frontal lobes.
- Quote paper
- Patrick Kimuyu (Author), 2018, Genetic and Neurobiological Basis of Schizophrenia, Munich, GRIN Verlag, https://www.hausarbeiten.de/document/411952
